123I-eptacog alfa (Novo Nordisk)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name123I-eptacog alfa (Novo Nordisk)
Drug Alias Name123I-FVIIa123I-factor VIIaiodine-123-FVIIaiodine-123-factor VIIaiodine-123-eptacog alfa (Novo Nordisk)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor VII stimulants
TargetsCoagulation factor VII
Therapy Area/IndicationsHemorrhage
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsHemorrhage

Other Information

ATC CodeN/A
Related LinksN/A